XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]        
Revenue $ 223,615 $ 811,020 $ 725,625 $ 806,338
Cost of revenue   206,421 189,754 206,052
Gross margin 168,455 604,599 535,871 600,286
Research, development, and engineering expenses   130,982 119,427 116,445
Selling, general, and administrative expenses   267,593 273,842 262,699
Restructuring charges 875 15,924 0 0
Intangible asset impairment charges 0 19,571 0 0
Operating income 59,085 170,529 142,602 221,142
Foreign currency gain (loss)   3,697 (509) (1,064)
Investment income   12,994 19,689 14,715
Other income (expense)   (309) 1,212 (219)
Income before income tax expense (benefit)   186,911 162,994 234,574
Income tax expense on continuing operations   10,725 (40,871) 15,307
Net income $ 69,345 $ 176,186 $ 203,865 $ 219,267
Net Income per weighted-average common and common-equivalent share:        
Net income (in dollars per share) $ 0.40 $ 1.02 $ 1.19 $ 1.27
Diluted earnings per weighted-average common and common-equivalent share (1):        
Net income (in dollars per share) 0.39 $ 1.00 $ 1.16 $ 1.24
Weighted-average common and common-equivalent shares outstanding:        
Basic (in shares)   173,489 171,194 172,333
Diluted (in shares)   176,592 175,269 177,406
Cash dividends per common share (in dollars per share) $ 2.00 $ 2.225 [1] $ 0.205 [1] $ 0.185 [1]
[1]
Prior period results have been adjusted to reflect the two-for-one stock split effected in the form of a stock dividend which occurred in the fourth quarter of 2017.

2